Barbara Ann Karmanos Cancer Institute — Detroit, Michigan

Public research footprint of Barbara Ann Karmanos Cancer Institute, compiled from the ClinicalTrials.gov public registry.

613

Registered studies

Active

Recruiting now

427

Completed

112

Stopped or withdrawn

Most-studied conditions

Multiple Myeloma · Non-small Cell Lung Cancer · Breast Cancer · Breast Neoplasms

Recently updated registry entries

NCT06158841 — Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard… (Recruiting)
NCT04557098 — A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma (Active Not Recruiting)
NCT04198766 — Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Barbara Ann Karmanos Cancer Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.